JAK
| Catalog No | Chemical Name | CAS Number | Purity | Chemical Structure |
|---|---|---|---|---|
| 18435 | Ritlecitinib ( PF-06651600 ) | 1792180-81-4 | ≧98.0% | _1792180-81-4.png) |
| Ritlecitinib ( PF-06651600 ) is a potent and selective JAK3 inhibitor. PF-06651600, a | ||||
| 1810163 | BMS-986165 | 1609392-27-9 | >99% |  |
| BMS-986165 potently binds to the Tyk2 pseudokinase domain (Ki = 0.02 nM). BMS-986165 | ||||
| 232251 | Brepocitinib ( PF-06700841 ) | 1883299-62-4 | ≧98.0% | _1883299-62-4.png) |
| Brepocitinib is a potential first-in-class dual, selective inhibitor of TYK2 and JAK1 | ||||
| 24028 | Golidocitinib ( AZD-4205 ) | 2091134-68-6 | ≧98.0% | _2091134-68-6.png) |
| Golidocitinib (AZD-4205) is an oral JAK1 selective kinase inhibitor. | ||||